Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [683]
News [2335]
Articles [179]
Editorials [6]
Conferences [88]
elearning [22]
ASCO 2023: Highlights and analysis
Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada
ASCO 2023: Highlights and analysis ( Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada )
6 Jun 2023
Neoadjuvant chemo with mFOLFIRINOX shows survival benefit in locally advanced...
Dr Thierry Conroy - Institute Cancer De Lorraine, Nancy, France
Neoadjuvant chemo with mFOLFIRINOX shows survival benefit in locally advanced rectal cancer ( Dr Thierry Conroy - Institute Cancer De Lorraine, Nancy, France )
5 Jun 2023
ATTRACTION-5: Nivolumab plus chemotherapy as postoperative adjuvant treatment...
Dr Masanori Terashima - Shizuoka Cancer Center, Nagaizumi, Japan
ATTRACTION-5: Nivolumab plus chemotherapy as postoperative adjuvant treatment for pStage III G/GEJ cancer ( Dr Masanori Terashima - Shizuoka Cancer Center, Nagaizumi, Japan )
3 Jun 2023
Maximising diagnosis of colon cancer with target screening
Dr Rimini Breakstone - Lifespan Cancer Institute, Rhode Island, USA
Maximising diagnosis of colon cancer with target screening ( Dr Rimini Breakstone - Lifespan Cancer Institute, Rhode Island, USA )
25 May 2023
Optimising colon cancer care in Nigeria
Dr Rimini Breakstone - Lifespan Cancer Institute, Rhode Island, USA
Optimising colon cancer care in Nigeria ( Dr Rimini Breakstone - Lifespan Cancer Institute, Rhode Island, USA )
25 May 2023
Tackling low-volumes of clinical trials in Africa
Prof Ifeoma Okoye - University of Nigeria, Nsukka, Nigeria
Tackling low-volumes of clinical trials in Africa ( Prof Ifeoma Okoye - University of Nigeria, Nsukka, Nigeria )
25 May 2023
The HypoAfrica study and AC3T research partnerships at NLCC
Dr Adedayo Joseph - NSIA-LUTH Cancer Center, Lagos, Nigeria
The HypoAfrica study and AC3T research partnerships at NLCC ( Dr Adedayo Joseph - NSIA-LUTH Cancer Center, Lagos, Nigeria )
17 May 2023
Achieving health equity in cancer care in the Philippines
Dr Rey Arturo Fernandez - Graduate School of Business, Makati City, The...
Achieving health equity in cancer care in the Philippines ( Dr Rey Arturo Fernandez - Graduate School of Business, Makati City, The Philippines )
10 May 2023
Targeting BRAF V600E in metastatic colorectal cancer: where are we today?
Dr Rodrigo Motta Guerrero - ALIADA Contra el Cáncer, San Isidro, Peru
Targeting BRAF V600E in metastatic colorectal cancer: where are we today? ( Dr Rodrigo Motta Guerrero - ALIADA Contra el Cáncer, San Isidro, Peru )
9 May 2023
Pembro plus gemcitabine and cisplatin potential option for metastatic or...
Dr Katie Kelley - University of California San Francisco, San Francisco, USA
Pembro plus gemcitabine and cisplatin potential option for metastatic or unresectable biliary tract cancer ( Dr Katie Kelley - University of California San Francisco, San Francisco, USA )
2 May 2023
Cetuximab with XELOX or XELIRI is tolerable and effective in RAS wild-type mCRC
Dr Jamal Zekri - King Faisal Specialist Hospital & Research Centre, Riyadh...
Cetuximab with XELOX or XELIRI is tolerable and effective in RAS wild-type mCRC ( Dr Jamal Zekri - King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia )
27 Apr 2023
CheckMate 649 biomarker analyses of NIVO + IPI vs chemo for patients with GC...
Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA
CheckMate 649 biomarker analyses of NIVO + IPI vs chemo for patients with GC/GEJC/EAC ( Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA )
26 Apr 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation